Yumi Sheehan is a Research Project Manager and PhD candidate at the Kirby Institute UNSW Sydney, managing several hepatitis C and prison-based research studies. Yumi’s specific research focus is on interventions to enhance hepatitis C care for people in prison, including point-of-care testing, surveillance, and education.

Aurelie Freismuth is a Doctor of Pharmacy. Her hospital internship focused on the cost-effectiveness of radiofrequency for the ablation of HCC and her doctorate thesis on the role of Oseltamivir in the treatment and prophylaxis of Influenza. Aurelie is currently Associate Director, Medical Affairs Liver diseases at Gilead Australia.

Amy Kwon is a mathematician at the Kirby Institute. Her research involves the development of mathematical models to understand the epidemiology of HCV and predict the impact of DAA therapy. She is responsible for providing the key HCV estimates of prevalence and HCV-attributed disease for Australia's Annual Surveillance Report.